Anticancers, Orphans & The First CAR-Ts: New EU Drug Approvals In 2018

 
• By Ian Schofield

New approvals in the EU were again dominated by oncology drugs in 2018, although medicines for infectious diseases were a close second. The number of orphan drugs more than doubled over the previous year, to 17. There were also some star arrivals in multiple sclerosis, genetic disorders, metabolism and migraine.

2019 2018 Perspectives
45 new medicines were approved in the EU in 2018.

More from New Products

More from Scrip